Freeline Therapeutics Holdings plc Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Freeline Therapeutics Holdings plc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q3 2023.
  • Freeline Therapeutics Holdings plc Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2023 was $3.93M, a 66.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $3.93M -$7.78M -66.5% Sep 30, 2023 6-K 2023-12-01
Q2 2023 $4.79M -$48.7M -91% Jun 30, 2023 6-K 2023-08-15
Q1 2023 $5.44M -$54.6M -91% Mar 31, 2023 6-K 2023-05-30
Q4 2022 $6.01M +$6.01M Dec 31, 2022 6-K 2023-12-01
Q3 2022 $11.7M Sep 30, 2022 6-K 2022-11-15
Q2 2022 $53.5M Jun 30, 2022 6-K 2022-08-09
Q1 2022 $60.1M Mar 31, 2022 6-K 2022-05-10
Q4 2021 $0 Dec 31, 2021 6-K 2022-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.